The renal epithelial sodium channel: genetic heterogeneity and implications for the treatment of high blood pressure - PubMed (original) (raw)

Review

The renal epithelial sodium channel: genetic heterogeneity and implications for the treatment of high blood pressure

G A Sagnella et al. Curr Pharm Des. 2006.

Abstract

The renal epithelial sodium channel (ENaC) is of fundamental importance in the control of sodium reabsorption through the distal nephron. ENaC is an important component in the overall control of sodium balance, blood volume and thereby of blood pressure. This is clearly demonstrated by rare genetic disorders of sodium channel activity (Liddle's Syndrome and Pseudohypoaldosteronism type 1 associated with contrasting effects on blood pressure). Subtle dysregulation of ENaC however may also be important in essential hypertension - a common condition and a major cause of cardiovascular morbidity and mortality. The epithelial sodium channel is formed from three partly homologous subunits. In this review we deals firstly with current views of structural and functional features of the renal epithelial sodium channel with particular emphasis on mechanisms and processes involved in the control of sodium channel activity at the biochemical and cellular levels. We then focus on genetic aspects with reference to the significance of genetic variation in the sodium channel genes in relation to blood pressure. In particular, we review recent investigations on the potential clinical significance of mutations within the genes encoding ENaC subunits in individuals with high blood pressure. Lastly, we also examine the potential value of pharmacological targeting of the renal epithelial sodium channel with the sodium channel inhibitor amiloride for the treatment of hypertension.

PubMed Disclaimer

Cited by

Role of natural herbs in the treatment of hypertension.
Tabassum N, Ahmad F. Tabassum N, et al. Pharmacogn Rev. 2011 Jan;5(9):30-40. doi: 10.4103/0973-7847.79097. Pharmacogn Rev. 2011. PMID: 22096316 Free PMC article.
Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide.
Duarte JD, Zineh I, Burkley B, Gong Y, Langaee TY, Turner ST, Chapman AB, Boerwinkle E, Gums JG, Cooper-Dehoff RM, Beitelshees AL, Bailey KR, Fillingim RB, Kone BC, Johnson JA. Duarte JD, et al. J Transl Med. 2012 Mar 22;10:56. doi: 10.1186/1479-5876-10-56. J Transl Med. 2012. PMID: 22440088 Free PMC article. Clinical Trial.
Bioactive molecules from terrestrial and seafood resources in hypertension treatment: focus on molecular mechanisms and targeted therapies.
Islam MR, Dhar PS, Akash S, Syed SH, Gupta JK, Gandla K, Akter M, Rauf A, Hemeg HA, Anwar Y, Aljohny BO, Wilairatana P. Islam MR, et al. Nat Prod Bioprospect. 2023 Oct 30;13(1):45. doi: 10.1007/s13659-023-00411-1. Nat Prod Bioprospect. 2023. PMID: 37902881 Free PMC article. Review.
An obligatory heterodimer of 14-3-3beta and 14-3-3epsilon is required for aldosterone regulation of the epithelial sodium channel.
Liang X, Butterworth MB, Peters KW, Walker WH, Frizzell RA. Liang X, et al. J Biol Chem. 2008 Oct 10;283(41):27418-27425. doi: 10.1074/jbc.M803687200. Epub 2008 Aug 7. J Biol Chem. 2008. PMID: 18687683 Free PMC article.
Purinoceptor: a novel target for hypertension.
Li X, Zhu LJ, Lv J, Cao X. Li X, et al. Purinergic Signal. 2023 Mar;19(1):185-197. doi: 10.1007/s11302-022-09852-8. Epub 2022 Feb 18. Purinergic Signal. 2023. PMID: 35181831 Free PMC article. Review.

The renal epithelial sodium channel: genetic heterogeneity and implications for the treatment of high blood pressure - PubMed (original) (raw)